Free shipping on all orders over $ 500

McN-A 343

Cat. No. M6941

All AbMole products are for research use only, cannot be used for human consumption.

McN-A 343 Structure
Size Price Availability Quantity
5mg USD 35 In stock
10mg USD 50 In stock
25mg USD 100 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

McN-A 343 is a selective muscarinic M1 receptor agonist. Selectivity for M1 over other muscarinic receptor types appears to arise from a high efficacy at M1 receptors.

Chemical Information
Molecular Weight 317.21
Formula C14H18Cl2N2O2
CAS Number 55-45-8
Form Solid
Solubility (25°C) Water 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Amory, et al. J Androl. Suppression of spermatogenesis by bisdichloroacetyldiamines is mediated by inhibition of testicular retinoic acid biosynthesis.

Related AChR/AChE Products
VU 0255035

VU 0255035 is a highly selective M1 muscarinic acetylcholine receptor (mAChR) antagonist (Ki = 14.87 nM).

Fesoterodine fumarate

Fesoterodine fumarate (Toviaz) is a novel muscarinic receptor antagonist.

SVT-40776

SVT-40776 is a novel M3 muscarinic receptor antagonist.

Aniracetam

Aniracetam is a compound that promotes intellectual development and neuroprotection.

Biperiden hydrochloride

Biperiden (KL 373) hydrochloride is a non-selective muscarinic receptor antagonist that competitively binds to M1 muscarinic receptors, thereby inhibiting acetylcholine and enhancing dopamine signaling in the central nervous system.

  Catalog
Abmole Inhibitor Catalog




Keywords: McN-A 343 supplier, AChR/AChE, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.